SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-202772
Filing Date
2009-10-02
Accepted
2009-10-02 16:03:00
Documents
3
Effectiveness Date
2009-10-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 30500
2 GRAPHIC g51458g42x21.jpg GRAPHIC 9064
3 GRAPHIC g51458g71i37.jpg GRAPHIC 15304
  Complete submission text file 0001193125-09-202772.txt   66088
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33004 | Film No.: 091102480
SIC: 2834 Pharmaceutical Preparations